Form 4: Boundless Bio CEO Zachary Hornby Acquires 295,000 Stock Options
SEC Form 4 Filing
Zachary Hornby, President & CEO of Boundless Bio, Inc., reports the acquisition of 295,000 stock options on January 22, 2025.
Summary
- On January 22, 2025, Zachary Hornby, the President & CEO of Boundless Bio, Inc., acquired 295,000 stock options.
- The options have an exercise price of $2.57.
- The stock options vest in 48 substantially equal monthly installments beginning on February 1, 2025.
- The options expire on January 21, 2035.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard reporting of stock option grants. The CEO acquiring options is generally a positive sign, but it's a routine part of executive compensation.
Positives
- The acquisition of stock options by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the transactions of company executives and directors.
Stakeholder Impact
- Shareholders may view the CEO's acquisition of stock options as a positive sign, aligning his interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 01/22/2025 | Date of transaction: Zachary Hornby acquired 295,000 stock options. |
| 02/01/2025 | Vesting start date: Stock options vest in 48 substantially equal monthly installments beginning on this date. |
| 01/21/2035 | Expiration date: Stock options expire on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.